Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: a multicentre audit
- PMID: 16120073
- PMCID: PMC1884769
- DOI: 10.1111/j.1365-2125.2005.02428.x
Potential for drug interactions involving cytochrome P450 in patients attending palliative day care centres: a multicentre audit
Abstract
Aim: To determine the potential for drug interactions involving cytochrome P450 (CYP) in patients receiving palliative day care.
Methods: Drugs used by patients attending four specialist palliative day care centres were reviewed to identify combinations that could result in a pharmacokinetic interaction via any of the five main human forms of CYP.
Results: Of 160 patients, 145 (91%) were prescribed at least one drug that was a substrate, inhibitor or inducer of one of the five main CYP isoforms. Twenty-four drug combinations, involving 34 patients, could have given rise to a clinically important interaction.
Conclusions: Prescribers should be aware that in this group of patients, one in five are at risk of a clinically important CYP-mediated drug interaction.
References
-
- Hospice and Palliative Care Facts and Figures 2003. The Hospice Information Service; http://www.hospiceinformation.info.
-
- Stockley IH. Drug Interactions. London: The Pharmaceutical Press; 2002.
-
- Twycross R, Wilcock A, Charlesworth S, Dickman A. Palliative Care Formulary. 2nd edn. Abingdon: Radcliff Medical Press; 2002. pp. 331–7.
-
- Bernard SA, Bruera E. Drug interactions in palliative care. J Clin Oncol. 2000;18:1780–99. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
